CAMP | CAMP4 Therapeutics Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.78 - 4.38
52 Week Range	3.50 - 12.30
Beta	2.93
Implied Volatility	174.20%
IV Rank	100.00%
Day's Volume	36,264
Average Volume	46,561
Shares Outstanding	20,161,074
Market Cap	80,644,296
Sector	Healthcare
Industry	Biotechnology
IPO Date	2024-10-11

Valuation
Profitability
Growth
Health
P/E Ratio	-1.52
Forward P/E Ratio	N/A
EPS	-2.64
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	58
Country	USA
Website	CAMP

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CAMP's peers: DZSI, HLIT, COMM, NTGR, CMTL, MYNA, KN, ITRN, AVNW, FEIM, DGII, ADTN, KVHI, TSAT, CASA, AMPG, ONDS, UTSI, ASNS

*Chart delayed

Analyzing fundamentals for CAMP we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see CAMP Fundamentals page.

Watching at CAMP technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on CAMP Technicals page.